Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE Some of the inconsistencies reported in the role of GST genotypes in lung cancer risk could be due to unexpected confounding from dietary factors. 11045782 2000
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 Biomarker disease BEFREE The association between ITC and cancer, and its modification by GST status, is most consistent for lung cancer and appears to be strongest among current smokers. 16019037 2005
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 PosttranslationalModification disease BEFREE The authors evaluated the promoter methylation of GST-M2 in lung cancer cells after treatment with the DNA methyltransferase (DNMT) inhibitor 5'-aza-2'-deoxycytidine (5'-aza-dC). 21246532 2011
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE The functional polymorphisms in GST genes play an important role in susceptibility to lung cancer. 18415801 2008
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE The human glutathione S-transferase (GST) P1 alleles coding for Val(105) (hGSTP1*B and/or P1*C) are over- represented in lung cancer patients. 10880766 2000
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 PosttranslationalModification disease BEFREE The presence of glutathione S-transferase (GST) pi1 (GSTP1) or multidrug resistance gene 1 (MDR1) promoter methylation in lung cancer was studied for the first time to the authors' knowledge; and, to date, the clinical significance of methylation is not clear. 19484794 2009
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 Biomarker disease BEFREE The relationships between smoking and the expression of glutathione S-transferase (GST*) isozymes GSTM1-1, GSTM3-3, GSTP1-1 and GSTA1-1/2-2 (GSTA1/2), or between smoking and activities of epoxide hydrolase (EH) and aryl hydrocarbon hydroxylase (AHH) were investigated in lung samples from 27 patients with lung cancer and 11 control patients by immunoblot analysis and enzyme assays. 7728947 1995
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE The results showed that the frequencies of glutathione S-transferase (GST) M1-null (GSTM1-) or GSTT1-null (GSTT1-) genotype alone, or combined form of both in lung cancer patients were significantly higher than those of the controls. 16788248 2006
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE The risk of lung and urinary bladder cancers was reported to be increased in individuals who carried high risk genotypes in either cytochrome P450 (CYP)1A1, CYP2E1 or glutathione S-transferase (GST)M1, and the combined genotype of both CYP1A1 and GSTM1 enzymes have an enhanced tendency of risk to lung cancer more significantly. 10022250 1998
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 Biomarker disease BEFREE Then, co-immunoprecipitation (Co-IP) and GST-pull down assays indicated that the candidate protein-SLC27A4 directly interacts with ATG4B in lung cancer cell lines. 26662804 2016
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 AlteredExpression disease BEFREE These results suggest that GST-pi gene expression is associated with chronic exposure to platinum drugs in lung cancer and/or the stress response to xenobiotics. 10840164 2000
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE Thus, genetic polymorphism of glutathione S-transferase (GST) can be recognized as a potential risk modifier in lung cancer development. 14628089 2003
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE To investigate the relationship between GST genotypes and lung cancer risk in Xuan Wei County, we analyzed GSTM1 and GSTT1 genotypes in a population-based case-control study. 10868696 2000
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 Biomarker disease BEFREE Treatment with ferulenol significantly increased the rate of lipid peroxidation and decrease enzymatic (CAT and GST) and non-enzymatic (GSH) anti-oxidants in benzo[a]pyrene induced lung cancer. 28270083 2017
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE We evaluated survival according to GST polymorphisms in a population-based series of lung cancer patients. 12814998 2003
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE We evaluated survival according to GST polymorphism in lung cancer patients. 16939958 2006
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 Biomarker disease BEFREE We found that high expressions of both GST-M2 and CCN2 are correlated with favorable survival of patients with lung cancer when compared with similar patients without GST-M2 or CCN2 expression. 23653452 2013
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE We investigated the independent and combined effects of the metabolic gene polymorphisms of NAT2 and GSTs on DNA adduct formation in different tissues (lung and blood) in lung cancer patients. 20501762 2010
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE We sought to determine whether GST activity in lung tissue is determined by the same gene polymorphism and whether it is associated with risk for lung cancer. 8485718 1993
Entrez Id: 133482
Gene Symbol: SLCO6A1
SLCO6A1
0.100 GeneticVariation disease BEFREE While adjusted odds ratios (ORs) indicated no significantly increased risk for lung cancer overall due to any single GST genotype, the risk alleles for GSTM1, GSTM3 and GSTP1 conferring reduced enzyme activity were present at higher frequency in SCC than in AC patients. 11740339 2001